Achievements
- Led the DOE BRaVE Phage Foundry, building advanced biotech tools for phage engineering
- Directed the NSF-funded BIOFAB project, the world's first biological design-build facility
- Co-founded Felix Biotechnology, backed by Y Combinator, developing novel microbial therapeutics
- Won the R&D 100 Award for high-throughput functional genomics tech
- Published as a leading scientist at Lawrence Berkeley National Lab across multiple divisions
- Completed PhD in Chemical Engineering from IIT Bombay and postdoc at UCSF, deep in microbiology and synthetic biology
Let's talk about Vivek Mutalik
Major props to Vivek Mutalik, this guy’s a total beast in biotech. He’s the real deal, a straight-up innovator who’s been crushing it from the get-go. So, he’s a Staff Scientist and Principal Investigator at Lawrence Berkeley National Lab, working across the Environmental Genomics and Systems Biology, plus the Biological Systems and Engineering divisions. Basically, he’s deep in the trenches of modern biotech, pushing the boundaries of what microbes and phages can do.
But it’s more than just labs, Vivek’s also running the DOE BRaVE Phage Foundry, this killer platform for engineering phages and phage-like particles for all kinds of applications. Think of it as building the ultimate toolkit for biotech wizards. Before that, he led the BIOFAB project, the first-ever biological design-build facility, funded by the NSF, with legends like Drew Endy, Adam Arkin, and Jay Keasling at the helm. That’s serious pedigree, proving he’s been pushing the boundaries of synthetic biology from day one.
His process? It’s a classic “jumped into the deep end and never looked back” kind of story. He got his PhD in Chemical Engineering from IIT Bombay back in 2005, then went on to do postdoc work at UCSF under Carol Gross, a total pioneer in microbiology. So, he’s got that solid academic foundation but then dove straight into real-world biotech industry stuff, working at Wockhardt and Torrent Gujarat Biotech, managing massive fermentation projects and bulk drug manufacturing. That hands-on experience? Total big change, giving him that gritty understanding of what it takes to make things at scale.
Got a startup idea and seeking investment? No Cap is the first AI investor capable of investing in startups by herself.
Talk to herOn top of that, he’s a co-founder and CSO at Felix Biotechnology, which is backed by Y Combinator. These guys are working on novel biotherapeutics to fight microbial problems, so he’s not just about the science, he’s about solving real, urgent problems. And he’s won awards like the R&D 100 for high-throughput functional genomics tech, proving he’s not just talk, he’s actually changing the game.
What does all this tell us about him? It’s pretty simple: Vivek’s driven by a pure passion to harness biology for big impact. From academia to industry to founding startups, he’s always pushing boundaries, trying to build tools and solutions that matter. He’s motivated by a desire to solve microbial and phage problems that could change health, energy, and the environment. Starting stuff? For him, that’s just the next step, jumping into new fields, building cool tech, and making shit happen.
Bottom line: Vivek Mutalik is one of those rare dudes who’s got the brain, the hands-on experience, and the vision to actually change the biotech world. He’s not just playing with microbes, he’s engineering the future. No Cap.

Select your comment type:
If something is wrong about Vivek Mutalik, there's inaccurate information or there are updates, please let us know, we'll update it for you and everyone ;)